Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lipkin

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of General Internal Medicine|August 2, 2006
Brief report: identifying a proxy for health care as part of routine medical inquiryK Michael Lipkin
Current Urology Reports|January 1, 2009
Medical therapy of stone disease: from prevention to promotion of passage optionsMichael Lipkin, Ojas Shah
Current Opinion in Urology|November 12, 2015
Imaging for urolithiasis: standards, trends, and radiation exposureMichael Lipkin, Anika Ackerman
Reviews in Urology|January 12, 2007
The use of alpha-blockers for the treatment of nephrolithiasisMichael Lipkin, Ojas Shah
The Journal of Urology|December 11, 2003
The impact of obstructive interval and sperm granuloma on outcome of vasectomy reversalStephen Boorjian, Michael Lipkin, Marc Goldstein
Urology|June 2, 2010
The preoperative use of erythropoietin stimulating proteins prior to radical prostatectomy is not associated with increased cardiovascular or thromboembolic morbidity or mortalityHerbert Lepor, Michael Lipkin, Denisa Slova
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 14, 2016
Outcomes of ureteroscopySarah Mozafarpour, Natalia Hernandez, Michael Lipkin, et al.
Urology|June 27, 2020
Letter to the Editor-ReplyRussell Terry, Kohldon Boydston, Michael Lipkin, et al.
Journal of Endourology|July 16, 2010
Heterogeneity in the reporting of disease characteristics and treatment outcomes in studies evaluating treatments for nephrolithiasisElias S Hyams, Aron Bruhn, Michael Lipkin, et al.
Urology|March 1, 2008
Minimally invasive management of retroperitoneal fibrosisMichael D Stifelman, Ojas Shah, Patrick Mufarrij, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of General Internal Medicine|August 2, 2006
Brief report: identifying a proxy for health care as part of routine medical inquiryK Michael Lipkin
Current Urology Reports|January 1, 2009
Medical therapy of stone disease: from prevention to promotion of passage optionsMichael Lipkin, Ojas Shah
Current Opinion in Urology|November 12, 2015
Imaging for urolithiasis: standards, trends, and radiation exposureMichael Lipkin, Anika Ackerman
Reviews in Urology|January 12, 2007
The use of alpha-blockers for the treatment of nephrolithiasisMichael Lipkin, Ojas Shah
The Journal of Urology|December 11, 2003
The impact of obstructive interval and sperm granuloma on outcome of vasectomy reversalStephen Boorjian, Michael Lipkin, Marc Goldstein
Urology|June 2, 2010
The preoperative use of erythropoietin stimulating proteins prior to radical prostatectomy is not associated with increased cardiovascular or thromboembolic morbidity or mortalityHerbert Lepor, Michael Lipkin, Denisa Slova
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 14, 2016
Outcomes of ureteroscopySarah Mozafarpour, Natalia Hernandez, Michael Lipkin, et al.
Urology|June 27, 2020
Letter to the Editor-ReplyRussell Terry, Kohldon Boydston, Michael Lipkin, et al.
Journal of Endourology|July 16, 2010
Heterogeneity in the reporting of disease characteristics and treatment outcomes in studies evaluating treatments for nephrolithiasisElias S Hyams, Aron Bruhn, Michael Lipkin, et al.
Urology|March 1, 2008
Minimally invasive management of retroperitoneal fibrosisMichael D Stifelman, Ojas Shah, Patrick Mufarrij, et al.
Pageof 3